Navigation Links
Roche unveils intelligent automation management solution at 2013 Clinical Lab Expo
Date:7/30/2013

HOUSTON, July 30, 2013 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety.

"This total lab automation solution can make a significant contribution to effective medical decision-making and higher efficiency in the medical laboratory," said Jack Phillips, president and CEO of Roche Diagnostics Corporation. "In addition to helping labs lower costs and minimize the risk of sample mix-ups, it offers short and predictable turnaround times to help physicians make fast and reliable treatment decisions for patients."

Using intelligent robotics, the cobas 8100 series automatically prepares blood samples for immediate testing and post-analytical processing, providing high-speed processing of up to 1,100 samples per hour. The system offers dynamic and efficient sample transport options and great flexibility, allowing labs to automate both routine and STAT tests. Healthcare professionals benefit from on-time, high quality diagnostic results for both routine and emergency tests, even at laboratory workload peaks.

The cobas 8100 series can easily be added onto Roche's existing cobas analyzers, and its flexible, modular design allows labs to grow over time as demand increases. Market availability in the U.S. is expected in 2015.

In addition to unveiling the cobas 8100 automated workflow series at the Clinical Lab Expo, Roche is sponsoring two workshops about critical industry issues in conjunction with the American Association for Clinical Chemistry (AACC) annual meeting:

  1. Improving Cardiac Test Turnaround Time by Collaboration Between the Lab and Emergency Department, a case study discussion by
    '/>"/>

SOURCE Roche Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. Rochester Medical Introduces Magic3® Coude Tip Hydrophilic Intermittent Catheter
3. Roche announces FDA approval of HIV viral load test
4. FDA clears Accu-Chek Combo system - Roches new interactive insulin pump system for people with diabetes
5. Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
6. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
7. Rochester Medical Reports Third Quarter Results
8. Roche receives FDA clearance for herpes simplex virus type 1 and 2 tests
9. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
10. Roche cytomegalovirus viral load test now available in US
11. Rochester Medical Announces Fourth Quarter 2012 Earnings Conference Call Tuesday, November 13, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Physicians and payers ... the biopharmaceutical market. Patients are better informed and ... and switching therapies. This shift in power is ... efforts toward patient-focused marketing. As part ... have learned it,s important to educate, communicate and ...
(Date:7/31/2015)... -- Seeger Weiss LLP is reporting that on July 13, 2015, ... C.R. Bard, the manufacturer of Inferior vena cava (IVC) ... the agency found at two of Bard,s facilities. Bard was ... them during Inspectional Observations that occurred on November 18, 2014, ... , location and on October 6, 2014, through November ...
(Date:7/31/2015)... 2015 Today, the National Association of ... issued a report urging greater accountability by the ... against websites illegally selling medications online. As detailed ... Program Progress Report for State and Federal Regulators: ... websites illegally distribute medications and avoid retribution. Such ...
Breaking Medicine Technology:Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3
... June 8, 2011 ForteBio®, Inc., a leading ... of biotherapeutic and pharmaceutical products, today announced the ... Fc Capture (AMC) biosensor for use on the ... high-throughput rapid kinetic characterization and screening of mouse ...
... 8, 2011 TetraLogic Pharmaceuticals, a biopharmaceutical company developing ... today announced the appointment of Mr. Jonathan B. Lloyd ... president of corporate development. Mr. Lloyd ... development and finance experience.  He has led negotiations, valuation ...
Cached Medicine Technology:ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies 2TetraLogic Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development 2
(Date:8/3/2015)... ... 2015 , ... Novatus, Inc. today launched the largest and ... as announced the date of its next major release. , Version 6.0 introduces ... as well as enhancements to the customer experience. Users now enjoy a ...
(Date:8/3/2015)... ... 03, 2015 , ... Results of a comprehensive survey by ... and Policy Analysis show widespread support for the U.S. Affordable Care Act among ... agreed that the controversial law passed in 2010 had “more good than bad” ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has been ... access to the tactics, techniques and practices required to design and develop highly ...
(Date:8/3/2015)... ... August 03, 2015 , ... The U.S. Food and Drug Administration (FDA) ... similar to deoxycholic acid, which occurs naturally in the body and helps absorb and ... this area of the body. These are invasive procedures and very expensive for most ...
(Date:8/3/2015)... ... ... A July 13 article from The Daily Mail titled "Jab That ... Can Last 'For Five Weeks'" discusses the use of stem cells to help ... harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal cells ...
Breaking Medicine News(10 mins):Health News:Novatus Unveils Milestone Software Release 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... , To The Editor: Recent deaths ... bacterial,infections in shellfish should remind people with certain ... shellfish,particularly during warm weather when waters in the ... of Vibrio vulnificus bacteria., Vibrio vulnificus is ...
... 15 Young Innovations, Inc.,(Nasdaq: YDNT ) today ... with a live and on-demand web cast conference call ... live audio broadcast of the,call will be available through ... broadcast will also be available through the,Company,s website, ...
... PARK, Calif., Oct. 15 Exponent, Inc.,(Nasdaq: EXPO ... ended,September 26, 2008., For the third quarter of ... $48,904,000, in the same period of 2007.,Revenues before reimbursements ... Net income was up 18% to $5,942,000, or $0.38 ...
... Hospice Pediatric Patients, WASHINGTON, Oct. 15 ... (USAID) and funding from the U.S.,President,s Emergency Plan ... has developed one of South Africa,s first children,s ... by youngsters with,life-threatening illnesses, including AIDS and cancer., ...
... University and Delta Dental Foundation project is working to ... of thousands of Indiana children, INDIANAPOLIS, Oct. 15 ... between January and September 2008 by an,Indiana University School of ... Indiana, a mobile dental sealant program operated by the,university and ...
... mathematician who has applied mathematical modeling techniques to elucidate the ... methods to ascertain the players most deserving of major league ... awards. Bukiet, a popular NJIT math professor, dives annually ... game, but also for his love of teaching and math. ...
Cached Medicine News:Health News:Important Health Issue From Be Oyster Aware 2Health News:Young Innovations, Inc. Provides Third Quarter Conference Call Details 2Health News:Exponent Reports Third Quarter 2008 Results 2Health News:Exponent Reports Third Quarter 2008 Results 3Health News:Exponent Reports Third Quarter 2008 Results 4Health News:Exponent Reports Third Quarter 2008 Results 5Health News:Exponent Reports Third Quarter 2008 Results 6Health News:Exponent Reports Third Quarter 2008 Results 7Health News:Exponent Reports Third Quarter 2008 Results 8Health News:Children with Life-Threatening Illnesses Receive Hospice Care 2Health News:SEAL Indiana Reports More Than Half of Indianapolis Area School Kids Treated by Program Have Moderate or Severe Dental Decay 2Health News:Using math model, NJIT professor names MVP and Cy Young award contenders 2Health News:Using math model, NJIT professor names MVP and Cy Young award contenders 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: